A meta-analysis of the proportion of antimicrobial resistant human Salmonella isolates in Ethiopia

BMC Pharmacology and Toxicology

Volumn 15, Issue 1, 2014, Pages

  Tadesse, Getachew ^a  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

Antimicrobial resistance; Ethiopia; Humans; Salmonella

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; ETHIOPIA; MULTIDRUG RESISTANCE; NONHUMAN; SALMONELLA; TIME; TREND STUDY; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; META ANALYSIS; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ETHIOPIA; HUMANS; MICROBIAL SENSITIVITY TESTS; SALMONELLA;

EID: 84926128597     PISSN: None     EISSN: 20506511     Source Type: Journal    
DOI: 10.1186/2050-6511-15-51     Document Type: Article

References (69)

1. Amábile-Cuevas CF: Global Perspectives of Antibiotic Resistance. In Antimicrobial Resistance in Developing Countries. Edited by Sosa AJ, Byarugaba DK, Amábile-Cuevas CF, Hsueh P, Kariuki S, Okeke IN. New York: Springer Science + Business Media; 2010:3-13.
2. Le Hello S, Harrois D, Bouchrif B, Sontag L, Elhani L, Guibert V, Zerouali K, Weill FX: Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. Lancet Infect Dis 2013, 13:672-679. doi.org/10.1016/S1473-3099 (13)70141-5.
3. Kariuki S, Revathi G, Kariuki N, Kiiru J, Mwituria J, Hart CA: Increasing prevalence of multidrug-resistant non-typhoidal Salmonellae, Kenya, 1994-2003. Int J Antimicrob Agents 2005, 25:38-43.
4. Coovadia YM, Gathiram V, Bhamjee A, Garratt RM, Mlisana K, Pillay N, Madlalose T, Short M: An outbreak of multiresistant Salmonella typhi in South Africa. Q J Med 1992, 82:91-100.
5. Niehaus AJ, Apalata T, Coovadia YM, Smith AM, Moodley P: An outbreak of foodborne salmonellosis in rural KwaZulu-Natal, South Africa. Foodborne Pathog Dis 2011, 8:693-697.
6. Mølbak K: Human Health Consequences of Antimicrobial Drug-Resistant Salmonella and Other Foodborne Pathogens. Clin Infect Dis 2005, 41:1613-1620.
7. Shimelis D, Tadesse Y: Clinical profile of acute renal failure in children admitted to the department of pediatrics, Tikur Anbessa Hospital. Ethiop Med J 2004, 42:17-22.
8. Shimeles D, Lulseged S: Clinical profile and pattern of infection in Ethiopian children with severe protein-energy malnutrition. East Afr Med J 1994, 71:264-267.
9. Tadesse G: Prevalence of human Salmonellosis in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis 2014, 14:88. doi:10.1186/1471-2334-14-88.
10. Pegram RG, Roeder PL, Hall ML, Rowe B: Salmonella in livestock and animal by-products in Ethiopia. Trop Anim Health Prod 1981, 13:203-207.
11. Morris D, Whelan M, Corbett-Feeney G, Cormican M, Hawkey P, Li X, Doran G: First report of extended-spectrum-beta-lactamase-producing Salmonella enterica isolates in Ireland. Antimicrob Agents Chemother 2006, 50:1608-1609.
12. Gebre-Yohannes A: Salmonella from Ethiopia: prevalent species and their susceptibility to drugs. Ethiop Med J 1985, 23:97-102.
13. Beyene G, Nair S, Asrat D, Mengistu Y, Engers H, Wain J: Multidrug resistant Salmonella Concord is a major cause of Salmonellosis in children in Ethiopia. J Infect Dev Ctries 2011, 5:23-33.
14. Hendriksen RS, Mikoleit M, Kornschober C, Rickert RL, Duyne SV, Kjelsø C, Hasman H, Cormican M, Mevius D, Threlfall J, Angulo FJ, Aarestrup FM: Emergence of multidrug-resistant Salmonella Concord infections in Europe and the United States in children adopted from Ethiopia 2003-2007. Pediatr Infect Dis J 2009, 28:814-818.
15. Vanhoof R, Gillis P, Stévart O, Boland C, Vandenberg O, Fux F, Collard J, Bertrand S: Transmission of multiple resistant Salmonella Concord from internationally adopted children to their adoptive families and social environment: proposition of guidelines. Eur J Clin Microbiol Infect Dis 2012, 31:491-497.
16. Fabre L, Delauné A, Espié E, Nygard K, Pardos M, Polomack L, Guesnier F, Galimand M, Lassen J, Weill FX: Chromosomal integration of the extended-spectrum beta-lactamase gene blaCTX-M-15 in Salmonella enterica serotype Concord isolates from internationally adopted children. Antimicrob Agents Chemother 2009, 53:1808-1816.
17. Galanis E, Lo Fo Wong DM, Patrick ME, Binsztein N, Cieslik A, Chalermchikit T, Aidara-Kane A, Ellis A, Angulo FJ, Wegener HC: Web-based surveillance and global Salmonella distribution, 2000-2002. Emerg Infect Dis 2006, 12:381-388.
18. Worku B: Typhoid fever in an Ethiopian children's hospital: 1984-1995. Ethiop J health Dev 2000, 14:311-315.
19. Animut A, Mekonnen Y, Shimelis D, Ephraim E: Febrile illnesses of different etiology among outpatients in four health centers in Northwestern Ethiopia. Jpn J Infect Dis 2009, 62:107-110.
20. Ley B, Le Hello S, Lunguya O, Lejon V, Muyembe JJ, Weill FX, Jacobs J: Invasive Salmonella enterica Serotype Typhimurium Infections, Democratic Republic of the Congo, 2007-2011. Emerg Infect Dis 2014, 20 doi.org/10.3201/eid2004.131488.
21. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, Ngetsa C, Slack MP, Njenga S, Hart CA: Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005, 352:39-47.
22. Gordon MA, Graham SM, Walsh AL, Phiri LW, Molyneux E, Zijlstra EE, Heyderman RS, Hart CA, Molyneux ME: Epidemics of invasive Salmonella enterica serovar Enteritidis and S. enterica serovar Typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis 2008, 46:963-969.
23. Fisk TL, Lundberg BE, Guest JL, Ray S, Barrett TJ, Holland B, Stamey K, Angulo FJ, Farley MM: Invasive infection with multidrug-resistant Salmonella enterica serotype Typhimurium definitive type 104 among HIV-infected adults. Clin Infect Dis 2005, 40:1016-1021.
24. Moher D, Liberati A, TetzlaffJ, Altman DG, The PRISMA Group: Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009, 6:e1000097. doi:10.1371/journal.pmed.1000097.
25. Tricco AC, Ng CH, Gilca V, Anonychuk A, Pham B, Berliner S: Canadian oncogenic human papillomavirus cervical infection prevalence: Systematic review and meta-analysis. BMC Infect Dis 2011, 11:235. doi:10.1186/1471-2334-11-235.
26. Calvo-Muñoz I, Gómez-Conesa A, Sánchez-Meca J: Prevalence of low back pain in children and adolescents: a meta-analysis. BMC Pediatr 2013, 13:14. doi:10.1186/1471-2431-13-14.
27. Hurley JC: Lack of impact of Selective Digestive Decontamination on Pseudomonas aeruginosa ventilator associated pneumonia: benchmarking the evidence base. J Antimicrob Chemother 2011, 66:1365-1373.
28. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
29. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
30. Yang Y, Li X, Zhou F, Jin Q, Gao L: Prevalence of Drug-Resistant Tuberculosis in Mainland China: Systematic Review and Meta-Analysis. PLoS One 2011, 6:e20343. doi:10.1371/journal.pone.0020343.
31. Gao L, Zhang L, Jin Q: Meta-analysis: prevalence of HIV infection and syphilis among MSM in China. Sex Transm Infect 2009, 85:354-358. doi:10.1136/sti.2008.034702.
32. Gedebou M, Tassew A: Antimicrobial resistance and R factor of Salmonella isolates from Addis Ababa. Ethiop Med J 1981, 19:77-85.
33. AshenafiM, Gedebou M: Salmonella and Shigella in adult diarrhoea in Addis Ababa-prevalence and antibiograms. Trans R Soc Trop Med Hyg 1985, 79:719-721.
34. Asrat D: Shigella and Salmonella serogroups and their antibiotic susceptibility patterns in Ethiopia. East Mediterr Health J 2008, 14:760-767.
35. Wolday D: Increase in the incidence of multidrug-resistant Salmonellae in Ethiopia. J Antimicrob Chemother 1998, 41:421-423.
36. Mache A, Mengistu Y, Cowley C: Salmonella serogroups identified from adult diarrhoeal out-patients in Addis Ababa Ethiopia: antibiotic resistance and plasmid profile analysis. East Afr Med J 1997, 74:183-186.
37. Mache A: Salmonella serogroup and their antibiotic resistance patterns isolated from diarrhoeal stools of pediatric out patients in Jimma Hospital and Jimma Health Center, South West Ethiopia. Ethiop J Health Sci 2002, 37:37-45.
38. Yismaw G, Negeri C, Kassu A, Tiruneh M, Mulu A: Antimicrobial Resistance Pattern of Salmonella Isolates from Gondar University Hospital, Northwest Ethiopia. Ethiop Pharm J 2007, 25:85-90.
39. Abera B, Biadglegne F: Antimicrobial resistance of fecal isolates of Salmonella and Shigella spp. at Bahir Dar regional health research laboratory, Northwest Ethiopia. Ethiop Pharm J 2009, 27:55-60.
40. Reda AA, Seyoum B, Yimam J, Andualem G, Fiseha S, Vandeweerd JM: Antibiotic susceptibility patterns of Salmonella and Shigella isolates in Harar, Eastern Ethiopia. J Infect Dis Immun 2011, 3:134-139.
41. Hendriksen RS, Kjelsø C, Torpdahl M, Ethelberg S, Mølbak K, Aarestrup FM: Upsurge of infections caused by Salmonella Concord among Ethiopian adoptees in Denmark. Euro Surveill 2010, 15:pii=19587.
42. Beyene G, Asrat D, Mengistu Y, Sofa A, Wain J: Typhoid fever in Ethiopia: Review. J Infect Dev Ctries 2008, 2:448-453.
43. Bauer AW, Kirby WM, Sherris JC, Turck M: Antibiotic Susceptibility Testing by a Standardized Single Disk Method. Am J Clin Pathol 1966, 45:493-496.
44. Desta Z, Abdulwhab M: Prescription writing in Gondar outpatient teaching hospital, Ethiopia. East Afr Med J 1996, 73:115-119.
45. Desalegn AA: Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, South Ethiopia: a cross-sectional study. BMC Health Serv Res 2013, 13:170. doi:10.1186/1472-6963-13-170.
46. Desta Z, Abula T, Beyene L, Fantahun M, Yohannes AG, Ayalew S: Assessment of rational drug use and prescribing in primary health care facilities in north west Ethiopia. East Afr Med J 1997, 74:758-763.
47. Fenta A, Belay M, Mekonnen E: Assessment of antibacterial drug exposure patterns of patient encounters seen by different categories of prescribers at health institutions in Bahir Dar, Ethiopia. Ethiop Med J 2013, 51:33-39.
48. Assessment of the Pharmaceutical Sector in Ethiopia. In [http://www.who. int/medicines/areas/coordination/Ethiopia-pharmaceutical.pdf]
49. Tsega B, Hailu W, Ergetie Z: Measuring quality of drug use in primary healthcare facilities: a yearlong assessment of WHO prescribing indicators, Wolkite town, South West Ethiopia. Int J Pharm & Ind Res 2012, 2:485-491.
50. Isah AO, Ross-Degnan D, Quick J, Laing R, Mabadeje AFB: The development of standard values for the WHO drug use prescribing indicators. In [http://archives.who.int/prduc2004/rducd/ICIUM_Posters/1a2_txt.htm]
51. Abula T, Worku A, Thomas K: Assessment of the dispensing practices of drug retail outlets in selected towns, North West Ethiopia. Ethiop Med J 2006, 44:145-150.
52. Suleman S, Ketsela A, Mekonnen Z: Assessment of self-medication practices in Assendabo Town Jimma zone, Southwestern Ethiopia. Res Soc Adm Pharm 2009, 5:76-81.
53. Angamo MT, Wabe NT, Raju NJ: Assessment of Patterns of Drug use by using World Health Organization's Prescribing Patient Care and Health facility indicators in Selected Health Facilities in Southwest Ethiopia. JAPS 2011, 1:62-66.
54. Molla B, Miko A, Pries K, Hildebrandt G, Klee J, Schroeter A, Helmuth R: Class 1 integrons and resistance gene cassettes among multidrug resistant Salmonella serovars isolated from slaughter animals and foods of animal origin in Ethiopia. Acta Trop 2007, 103:142-149.
55. Abera B, Biadegelgen F, Bezabih B: Prevalence of Salmonella typhi and intestinal parasites among food handlers in Bahir Dar Town, North West Ethiopia. Ethiop J Health Dev 2010, 24:46-50.
56. Aragaw K, Molla B, Muckle A, Cole L, Wilkie E, Poppe C, Kleer J, Hildebrandt G: The characterization of Salmonella serovars isolated from apparently healthy slaughtered pigs at Addis Ababa abattoir, Ethiopia. Prev Vet Med 2007, 82:252-261.
57. Alemayehu D, Molla B, Muckle A: Prevalence and antimicrobial resistance pattern of Salmonella isolates from apparently healthy slaughtered cattle in Ethiopia. Trop Anim Health Prod 2003, 35:309-319.
58. Molla B, Salah W, Alemayehu D, Mohammed A: Antimicrobial resistance pattern of Salmonella serotypes isolated from apparently healthy slaughtered camels (Camelus dromedarius) in Eastern Ethiopia. Berl Münch Tierärztl Wschr 2004, 117:39-45.
59. Molla W, Molla B, Alemayehu D, Muckle A, Cole L, Wilkie E: Occurrence and antimicrobial resistance of Salmonella serovars in apparently healthy slaughtered sheep and goats of central Ethiopia. Trop Anim Health Prod 2006, 38:455-462.
60. Sibhat B, Zewde BM, Zerihun A, Muckle A, Cole L, Boerlin P, Wilkie E, Perets A, Mistry K, Gebreyes WA: Salmonella serovars and antimicrobial resistance profiles in beef cattle, slaughterhouse personnel and slaughterhouse environment in Ethiopia. Zoonoses Public Hlth 2011, 58:102-109.
61. Alemu S, Zewde BM: Prevalence and antimicrobial resistance profiles of Salmonella enterica serovars isolated from slaughtered cattle in Bahir Dar, Ethiopia. Trop Anim Health Prod 2012, 44:595-600.
62. Kingsley RA, Msefula CL, Thomson NR: Epidemic multiple drug resistant Salmonella typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res 2009, 19:2279-2287.
63. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA: Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 2012, 379:2489-2499.
64. Leibovitz E: The use of fluoroquinolones in children. Curr Opin Pediatr 2006, 18:64-70.
65. Ferrera KP, Bomasang ES: Azithromycin versus First Line Antibiotics in the Therapeutic Management of Documented Cases of Typhoid Fever: A Meta-analysis. Phil J Microbiol Infect Dis 2004, 33:163-168.
66. Frenck RW, Nakhla I, Sultan Y, Bassily SB, Girgis YF, David J, Butler TC, Girgis NI, Morsy M: Azithromycin versus Ceftriaxone for the Treatment of Uncomplicated Typhoid Fever in Children. Clin Infect Dis 2000, 31:1134-1138.
67. Keenan JD, Ayele B, Gebre T, Zerihun M, Zhou Z, House JI, Gaynor BD, Porco TC, Emerson PM, Lietman TM: Childhood mortality in a cohort treated with mass azithromycin for trachoma. Clin Infect Dis 2011, 52:883-888.
68. Chuc NT, Larsson M, Do NT, Diwan VK, Tomson GB, Falkenberg T: Improving private pharmacy practice: a multi-intervention experiment in Hanoi Vietnam. J Clinic Epidemiol 2002, 55:1148-1155.
69. Laing R, Hogerzeil H, Ross-Degnan D: Ten recommendations to improve use of medicines in developing countries. Health Policy Plan 2001, 16:13-20.